SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-17-005236
Filing Date
2017-05-15
Accepted
2017-05-15 08:44:18
Documents
68
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 599813
2 ex10-4.htm EX-10.4 25138
3 ex31-1.htm EX-31.1 17275
4 ex31-2.htm EX-31.2 17361
5 ex32-1.htm EX-32.1 5460
6 ex32-2.htm EX-32.2 5702
7 image_001.jpg GRAPHIC 5357
  Complete submission text file 0001493152-17-005236.txt   2848480

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE vbiv-20170331.xml EX-101.INS 396667
9 XBRL SCHEMA FILE vbiv-20170331.xsd EX-101.SCH 44100
10 XBRL CALCULATION FILE vbiv-20170331_cal.xml EX-101.CAL 50976
11 XBRL DEFINITION FILE vbiv-20170331_def.xml EX-101.DEF 123688
12 XBRL LABEL FILE vbiv-20170331_lab.xml EX-101.LAB 254474
13 XBRL PRESENTATION FILE vbiv-20170331_pre.xml EX-101.PRE 197506
Mailing Address 222 THIRD STREET SUITE 2241 CAMBRIDGE MA 02142
Business Address 222 THIRD STREET SUITE 2241 CAMBRIDGE MA 02142 617-830-3031
VBI Vaccines Inc/BC (Filer) CIK: 0000764195 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-37769 | Film No.: 17841347
SIC: 2834 Pharmaceutical Preparations